Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Adolescents with PCOS have higher levels of certain androgens, which are linked to hair growth but don't help diagnose PCOS better than testosterone levels.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Pitx2 helps outer root sheath cells differentiate but can't start hair growth on its own.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

Adding more glutathione to the preservation solution doesn't reduce oxidative stress in hair transplants.

Calcium reduces involucrin in rat hair bulbs but doesn't affect filaggrin and Kdap.

Many Chinese patients lose hair after weight loss surgery, especially women, and taking iron and zinc on their own doesn't help.

Breathing in fine particles or Asian dust short-term doesn't affect schoolchildren's skin symptoms.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Obese women with PCOS are more likely to have fatty liver disease.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.